These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31200678)

  • 1. The effect of mild agonist stimulation on the platelet reactivity in patients with type 2 diabetes mellitus.
    Mahmoodian R; Salimian M; Hamidpour M; Khadem-Maboudi AA; Gharehbaghian A
    BMC Endocr Disord; 2019 Jun; 19(1):62. PubMed ID: 31200678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships between optical aggregometry (type born) and flow cytometry in evaluating ADP-induced platelet activation.
    Sbrana S; Della Pina F; Rizza A; Buffa M; De Filippis R; Gianetti J; Clerico A
    Cytometry B Clin Cytom; 2008 Jan; 74(1):30-9. PubMed ID: 17630652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of prasugrel on ADP-stimulated markers of platelet activation in patients with sickle cell disease.
    Jakubowski JA; Zhou C; Winters KJ; Lachno DR; Howard J; Payne CD; Mant T; Jurcevic S; Frelinger AL
    Platelets; 2015; 26(5):474-9. PubMed ID: 25140584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of flow cytometry in the measurement of platelet activation and aggregation in human immunodeficiency virus infection.
    Nkambule BB; Davison G; Ipp H
    Platelets; 2015; 26(3):250-7. PubMed ID: 24831969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of P-selectin (CD62P) on platelets after thrombin and ADP in hypotrophic and healthy, full-term newborns.
    Wasiluk A; Kemona H; Mantur M; Polewko A; Ozimirski A; Milewski R
    J Matern Fetal Neonatal Med; 2013 Sep; 26(13):1321-4. PubMed ID: 23484959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The periodontal anaerobe Porphyromonas gingivalis induced platelet activation and increased aggregation in whole blood by rat model.
    Yu KM; Inoue Y; Umeda M; Terasaki H; Chen ZY; Iwai T
    Thromb Res; 2011 May; 127(5):418-25. PubMed ID: 21334044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise-induced platelet and leucocyte activation is not enhanced in well-controlled Type 1 diabetes, despite increased activity at rest.
    Hu H; Johansson BL; Hjemdahl P; Li N
    Diabetologia; 2004 May; 47(5):853-9. PubMed ID: 15095037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous assay of activated platelet count and platelet-activating capacity by P-selectin detection using K2-EDTA-treated whole blood for antiplatelet agents.
    Okano K; Araki M; Mimura Y; Nogaki H; Ichihara K
    Int J Lab Hematol; 2012 Dec; 34(6):621-9. PubMed ID: 22862794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of delta value of platelet parameters on ADVIA 120 for the functional reactivity of stored platelets.
    Park IJ; Lim YA; Cho SR
    J Clin Lab Anal; 2010; 24(1):38-43. PubMed ID: 20087952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet function alterations and their relation to P-selectin (CD62P) expression in children with iron deficiency anemia.
    Yıldırım ZK; Orhan MF; Büyükavcı M
    Blood Coagul Fibrinolysis; 2011 Mar; 22(2):98-101. PubMed ID: 21245745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of halothane and isoflurane on binding of ADP- and TRAP-6- activated platelets to leukocytes in Whole blood.
    de Rossi LW; Horn NA; Hecker KE; Robitzsch T; Hutschenreuter G; Rossaint R
    Anesthesiology; 2002 Jan; 96(1):117-24. PubMed ID: 11753011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Submission for Special Issue: The Role of Platelet Activation in the Pathophysiology of HIV, Tuberculosis, and Pneumococcal Disease. Bedaquiline Suppresses ADP-Mediated Activation of Human Platelets
    Tintinger GR; Theron AJ; Steel HC; Cholo MC; Nel JG; Feldman C; Anderson R
    Front Immunol; 2020; 11():621148. PubMed ID: 33717055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels.
    Tan KT; Tayebjee MH; Lim HS; Lip GY
    Diabet Med; 2005 Dec; 22(12):1657-62. PubMed ID: 16401308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of diabetes on platelet activation in different manifestations of atherosclerosis.
    Gremmel T; Kopp CW; Seidinger D; Koppensteiner R; Steiner S; Panzer S
    Swiss Med Wkly; 2013; 143():w13800. PubMed ID: 23740526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dopamine agonism on ADP-stimulated platelets is mediated through D2-like but not D1-like dopamine receptors.
    Schedel A; Schloss P; Klüter H; Bugert P
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Oct; 378(4):431-9. PubMed ID: 18542926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphatidylserine expression on the platelet membrane of patients with myeloproliferative disorders and its effect on platelet-dependent thrombin formation.
    Presseizen K; Friedman Z; Shapiro H; Radnay J; Ellis MH
    Clin Appl Thromb Hemost; 2002 Jan; 8(1):33-9. PubMed ID: 11991237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between albuminuria and spontaneous platelet microaggregate formation in type 2 diabetic patients.
    Araki S; Matsuno H; Haneda M; Koya D; Kanno Y; Itho J; Kishi A; Isshiki K; Sugimoto T; Maegawa H; Kashiwagi A; Uzu T
    Diabetes Care; 2009 Nov; 32(11):2062-7. PubMed ID: 19675198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the aggregation responses of camel platelets.
    Al Ghumlas AK; Gader AG
    Vet Clin Pathol; 2013 Sep; 42(3):307-13. PubMed ID: 23919654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed inhibition of agonist-induced granulocyte-platelet aggregation after low-dose sevoflurane inhalation in humans.
    Wacker J; Lucchinetti E; Jamnicki M; Aguirre J; Härter L; Keel M; Zaugg M
    Anesth Analg; 2008 Jun; 106(6):1749-58. PubMed ID: 18499605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvianolic acid a inhibits platelet activation and aggregation in patients with type 2 diabetes mellitus.
    Zhou AM; Xiang YJ; Liu EQ; Cai CH; Wu YH; Yang LB; Zeng CL
    BMC Cardiovasc Disord; 2020 Jan; 20(1):15. PubMed ID: 31931718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.